Hancock Jaffe Laboratories Inc Capitalización de mercado
¿Qué es el Capitalización de mercado de Hancock Jaffe Laboratories Inc?
El Capitalización de mercado de Hancock Jaffe Laboratories Inc es $88.37M
¿Cuál es la definición de Capitalización de mercado ?
La capitalización de mercado es el valor de mercado en un momento en el tiempo de las acciones en circulación de una empresa que cotiza en bolsa, que es igual al precio de la acción en ese punto de tiempo por el número de acciones en circulación .
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Capitalización de mercado de compañías en Sector Health Care en NASDAQ en comparadas con Hancock Jaffe Laboratories Inc
¿Qué hace Hancock Jaffe Laboratories Inc?
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.
Empresas con capitalización de mercado similar a Hancock Jaffe Laboratories Inc
- TruFin plc tiene Capitalización de mercado de $88.25M
- EBR Systems tiene Capitalización de mercado de $88.27M
- Mobivity tiene Capitalización de mercado de $88.29M
- LHN tiene Capitalización de mercado de $88.33M
- Lacroix SA tiene Capitalización de mercado de $88.34M
- Mountain Province Diamonds tiene Capitalización de mercado de $88.35M
- Hancock Jaffe Laboratories Inc tiene Capitalización de mercado de $88.37M
- Nuveen Municipal Income Fund tiene Capitalización de mercado de $88.41M
- Westwood Inc tiene Capitalización de mercado de $88.47M
- Nuveen Mortgage and Income Fund tiene Capitalización de mercado de $88.49M
- Youfoodz tiene Capitalización de mercado de $88.52M
- AfriTin Mining tiene Capitalización de mercado de $88.52M
- Sol Cuisine Ltd tiene Capitalización de mercado de $88.52M